How can patient adherence to secondary prevention therapies be improved after an acute coronary syndrome?
Improving adherence to secondary prevention therapies after ACS requires a multifaceted approach involving early follow-up, patient education, and novel interventions.
Patient nonadherence to guideline-recommended long-term pharmacologic secondary preventative therapies after ACS is multifactorial. A comprehensive multifaceted approach should be implemented to improve adherence and clinical outcomes. This approach should include key interventions such as early follow-up visits, high medication adherence at 90 days, patient engagement and education, and development of novel interventions that support the 3 broad categories influencing patient adherence as discussed in this review.
Bahit et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: